Cosmos Health Inc. agreed to Spin-Off Research and development (R&D) division of Cosmos Health Inc. on September 27, 2023. Cosmos Health has determined that spinning off its R&D division into a standalone, well-capitalized, publicly listed biotech entity will best serve its shareholders.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.695 USD | +0.72% | +3.89% | -50.35% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.35% | 11.62M | |
+20.88% | 72.78B | |
-2.03% | 24.24B | |
+8.80% | 8.59B | |
+9.15% | 8.38B | |
-17.39% | 8.09B | |
+7.33% | 4.81B | |
+17.69% | 4.32B | |
-3.66% | 4.05B | |
-2.54% | 3.93B |
- Stock Market
- Equities
- COSM Stock
- News Cosmos Health Inc.
- Cosmos Health Inc. agreed to Spin-Off Research and development (R&D) division of Cosmos Health Inc.